Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials
Author:
Affiliation:
1. Chris O'Brien Lifehouse; Camperdown New South Wales Australia
2. Royal Prince Alfred Hospital; Camperdown New South Wales Australia
3. Sydney Medical School; University of Sydney; New South Wales Australia
Publisher
Wiley
Subject
Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12864/fullpdf
Reference66 articles.
1. Achievement of optimal average relative dose intensity and correlation with survival in diffuse large b-cell lymphoma patients treated with chop;Bosly;Ann Hematol,2008
2. Intensive and timely chemotherapy, the key of success in testicular cancer;Flechon;Crit Rev Oncol Hematol,2001
3. Docetaxel and cyclophosphamide as adjuvant chemotherapy for early breast cancer: primary prophylaxis with g-CSF is required;Lakhanpal;Breast Cancer Manage,2013
4. Eligibility of patients with advanced non-small cell lung cancer for phase iii chemotherapy trials;Vardy;BMC Cancer,2009
5. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer;Jones;J Clin Oncol,2006
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CT-derived body composition and differential association with age, TNM stage and systemic inflammation in patients with colon cancer;Scientific Reports;2024-07-08
2. Palliative care for cancer patients using methods of integrative psychology and nutritionology;International Journal of Medicine and Psychology;2024-03-28
3. The role of grip strength and short physical performance battery test in predicting chemotherapy-related outcomes in older adults with cancer;Journal of Geriatric Oncology;2021-12
4. Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy—a retrospective analysis of a register-based patient cohort;European Journal of Clinical Pharmacology;2020-05-05
5. Multicomponent nutritional supplement Oncoxin and its influence on quality of life and therapy toxicity in patients receiving adjuvant chemotherapy;Oncology Letters;2019-09-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3